BULLETIN OF THE WORLD HEALTH ORGANIZATION世界卫生组织公报
BULLETIN OF THE WORLD HEALTH ORGANIZATION(英文缩写 B WORLD HEALTH ORGAN),ISSN 0042-9686,eISSN 1564-0604,中文译名:世界卫生组织公报 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-11-01 至 2026-10-31，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 13.831 | Q1 |
| 2022 | 11.100 | Q1 |
| 2023 | 8.400 | Q1 |
| 2024 | 5.700 | Q1 |
| 2025 | 6.900 | Q1 |
BULLETIN OF THE WORLD HEALTH ORGANIZATION 最新收录文献
-
3. A case for eliminating Widal testing for enteric fever, India.
3. 关于在印度消除伤寒Widal试验的论证PMID:日期:2026-10-01该文献暂无摘要。
-
4. Global plastics treaty negotiations and health-care system use of plastics, WHO African Region.
4. 全球塑料条约谈判与医疗保健系统的塑料使用，世界卫生组织非洲区域PMID:日期:2026-10-01该文献暂无摘要。
-
5. Improvements to pharmaceutical manufacturing capacity, Ethiopia.
PMID:日期:2026-09-01Ethiopia's heavy dependence on imported pharmaceuticals created public health vulnerabilities, foreign exchange pressures and recurrent medicine stock-outs. In 2015, Ethiopia launched a 10-year National Strategy and Plan of Action for Pharmaceutical Manufacturing Development to improve access to quality-assured medicines. The strategy, overseen by a Joint Steering Committee co-chaired by the Ministries of Health and Industry with technical assistance from the World Health Organization (WHO), combined industrial incentives, preferential centralized procurement and regulatory strengthening. Before strategy implementation, Ethiopia had limited manufacturing capacity. Local manufacturers supplied approximately 20% of national generic medicine demand, while supply chain fragmentation and foreign exchange constraints compromised access to imported medicines. By 2025, six facilities had achieved national good manufacturing practice compliance, 11 manufacturers were operational and the Ethiopian Food and Drug Authority reached WHO Maturity Level 3. Locally produced coverage of the National Essential Medicines List increased from 90 to 140 chemical entities, across 167 dosage forms, and a vaccine manufacturing initiative was launched. However, domestic supply only increased to 23% against a 60% public procurement target; active pharmaceutical ingredient production and WHO prequalification remained unachieved, and export and workforce targets were missed. Combined, the strategy's cross-sectoral governance, regulatory strengthening, preferential centralized procurement and industrial incentives advanced local production. However, foreign exchange constraints, dependence on imported raw materials and financing and capacity gaps limited progress. Future efforts should prioritize WHO prequalification, upstream manufacturing, skilled workforce development, export competitiveness and sustainable financing while maintaining patient-centred objectives.
-
7. Seasonal malaria chemoprevention effectiveness and drug resistance in Plasmodium falciparum: a matched parallel cohort study, Kenya.
7. 肯尼亚恶性疟原虫季节性疟疾化学预防效果与耐药性：一项匹配平行队列研究PMID:日期:2026-09-01To evaluate seasonal malaria chemoprevention with sulfadoxine-pyrimethamine and amodiaquine in a semi-nomadic community in north-western Kenya, and to examine the relationship between parasite resistance and breakthrough infections. A parallel cohort study conducted during the peak malaria season in 2024 involved 10 randomly selected villages in Turkana Central subcounty, where children younger than 5 years received seasonal malaria chemoprevention, and 10 matched villages in Turkana North subcounty (non-intervention cohort). We conducted surveillance of malaria symptoms weekly. The primary outcome was malaria-like symptoms plus a positive rapid diagnostic test result. We analysed genomic DNA in dried blood spot samples from children with symptomatic infections to identify and gene substitutions associated with sulfadoxine-pyrimethamine resistance. Children (198 in the intervention cohort and 200 in the non-intervention cohort) were followed until four weeks after the last chemoprevention cycle. In the intervention cohort, 72% (143/198) completed all five cycles. The incidence of malaria was significantly lower in the intervention than non-intervention cohort (adjusted incidence rate ratio 0.29; 95% confidence interval: 0.13-0.67). genomic DNA analysis of samples from 68 infected children showed that gene mutations were more common in the intervention than non-intervention cohort and became more frequent as the number of treatment cycles increased. Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine and amodiaquine was associated with substantial protection against malaria in children in an area where sulfadoxine-pyrimethamine resistance was common. Treated children were more likely to harbour resistant parasites.
-
8. Accountability for large language models in health care.
8. 大型语言模型在医疗保健中的问责制PMID:日期:2026-09-01Large language models are entering clinical workflows faster than health-care institutions can assign responsibility for their failures. This situation is creating governance gaps with consequences that extend beyond individual patients to public health systems. The result is an accountability vacuum in which responsibility for harm mediated by large language models can be spread across clinicians, institutions and vendors. This responsibility gap distributes harm inequitably, particularly in low- and middle-income countries where regulatory infrastructure for digital health is still developing. We propose earned delegation as a predeployment standard: authority should be delegated only when evidence is proportionate to clinical risk, substantive human oversight is integrated and resourced, and responsibility for foreseeable failure modes is assigned in advance. To operationalize this standard, health systems should adopt a predeployment accountability charter specifying intended use, excluded use, validation evidence, oversight design, escalation pathways, auditability, subgroup performance review and named accountable parties. The charter should be integrated into existing institutional review, accreditation and procurement structures. Earned delegation provides a governance framework that health ministries, regulators and institutional leaders can adopt to ensure that use of large language models serves public health goals without outpacing them.
-
9. Ways to address health financing pressures and donor transition, Kenya.
PMID:日期:2026-09-01该文献暂无摘要。
-
10. Capacity for national health policy modelling, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates.
PMID:日期:2026-08-20Gulf Cooperation Council countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates) have similar governance structures, economic profiles and health system organization, creating an opportunity for collective action on health. Similarly, these countries have the same challenges including ageing populations, climate and heat risks, immigration, service delivery and disease profiles. We argue for the need to shift from opinion-driven policy discourse to computer-based, decision-focused policy analysis that is participatory, aware of inherent uncertainties surrounding decisions and context-specific. Despite areas of excellence, modelling capacity in these countries is fragmented and underresourced and models are rarely used to guide decision-making. The coronavirus disease 2019 pandemic saw very few decision-oriented models tied to local data from Gulf Cooperation Council countries. Gulf Cooperation Council models rely on outside modellers, which limits both the relevance and ownership of the findings. The coming decade will bring challenges that demand a change in how evidence is generated and applied. A structured, regionally anchored policy-modelling system can help governments test reforms, prioritize investments and engage in scenario planning before crises force reactive measures. Our paper outlines pragmatic steps towards effective health policy modelling based on four supporting pillars: (i) a regional co-produced modelling and knowledge translation strategy tied to priority decisions; (ii) embedded capacity-building across ministries, public health institutes and universities; (iii) a viable modelling stack that allows transparency, speed and reproducibility; and (iv) explicit communication and evaluation of the uncertainty of models to reduce risks within the choices made.